Oncology

News

Daiichi Sankyo partners Alteogen on subcutaneous Enhertu

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu.

News

Scientist in a laboratory with sequencer

NHS Wales partners with Illumina on genomics drive

Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina.

News

Alligator pancreatic cancer drug 'nearly doubles' survival

Alligator Bioscience has reported updated results with its CD40 agonist mitazalimab as a first-line treatment for advanced pancreatic cancer, a disease with few treatment options.<

News

Lab space in CRUK's Paterson Building in Manchester

CRUK backs AI-powered, virtual radiotherapy trial projects

Cancer Research UK has provided £5.9 million ($7.7 million) in funding to a project that will explore the use of artificial intelligence in trials of radiotherapy treatments, as well as vir

News

iPhone app for throat cancer camera technology attachment

NHS pilots iPhone app to rule out throat cancer

NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up reviews of suspected throat cancer.

Oncology

Juggling CMC trade-offs with personalised cancer vaccines

Personalised cancer vaccines offer significant potential to address an unmet medical need in treatment-resistant disease with fewer side effects and less toxicity compared to standard treat

Daiichi Sankyo partners Alteogen on subcutaneous Enhertu

NHS Wales partners with Illumina on genomics drive

Alligator pancreatic cancer drug 'nearly doubles' survival

CRUK backs AI-powered, virtual radiotherapy trial projects

NHS pilots iPhone app to rule out throat cancer

Juggling CMC trade-offs with personalised cancer vaccines

Australia starts probe into AI infiltration of Medicare

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks